19
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Sex and Gender in Neurodegenerative Diseases

      Submit here before September 30, 2024

      About Neurodegenerative Diseases: 3.0 Impact Factor I 4.3 CiteScore I 0.695 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      High Incidence Rates of Stroke in Örebro, Sweden: Further Support for Regional Incidence Differences within Scandinavia

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and Purpose: As a basis for comparison of differences in stroke incidence in Scandinavian countries, a community-based stroke register was established in Örebro in the centre of Sweden. Methods: All first-ever cases of stroke were registered during a 12-month period 1999–2000. The study population was 123,503. The WHO definition of stroke was used. Cases were searched inside as well as outside hospital. Multiple overlapping sources and ‘hot pursuit’ technique were used in the process of case ascertainment. Results: 388 cases of first-ever stroke were found, corresponding to a crude incidence rate of 314 (95% CI, 283–348) per 100,000 per year, 337 (95% CI, 294–386) for females, and 289 (95% CI, 248–336) for males. Adjusted to the European population, the corresponding rates were 254 (95% CI, 227–284) per 100,000 per year, 273 (95% CI, 238–311) for females and 232 (95% CI, 206–261) for males. The overall 28-day case-fatality rate was 19% (95% CI, 15–23). The case-fatality rates for the different subtypes of stroke were as follows: brain infarction, 10%; intracerebral haemorrhage, 20%; subarachnoidal haemorrhage 45%, and undetermined pathological type 56%. Conclusions: The present study as well as other studies in northern and middle Scandinavia show significantly higher incidence rates than studies from other regions. The crude incidence rate, reflecting the age distribution of the population, is even higher, indicating a burden to the community that is rather increasing than decreasing.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: not found
          • Article: not found

          Tumour pH

          (1992)
            Bookmark

            Author and article information

            Journal
            CED
            Cerebrovasc Dis
            10.1159/issn.1015-9770
            Cerebrovascular Diseases
            S. Karger AG
            1015-9770
            1421-9786
            2002
            October 2002
            25 October 2002
            : 14
            : 3-4
            : 161-168
            Affiliations
            aDepartments of Neurology and Geriatrics, Örebro University Hospital, Örebro, bNeurotec Department, Karolinska Institutet, Stockholm, and cDepartment of Medicine, University of Uppsala, Sweden
            Article
            65680 Cerebrovasc Dis 2002;14:161–168
            10.1159/000065680
            12403948
            df9b4379-c24b-4f41-8b7e-cc4f303b655a
            © 2002 S. Karger AG, Basel

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            History
            : 09 November 2001
            : 09 April 2002
            Page count
            Tables: 5, References: 40, Pages: 8
            Categories
            Original Paper

            Geriatric medicine,Neurology,Cardiovascular Medicine,Neurosciences,Clinical Psychology & Psychiatry,Public health
            Epidemiology,Cerebrovascular diseases,Sweden,Incidence

            Comments

            Comment on this article